GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (FRA:TD5A) » Definitions » Total Liabilities

Tandem Diabetes Care (FRA:TD5A) Total Liabilities : €709.3 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Tandem Diabetes Care Total Liabilities?

Tandem Diabetes Care's Total Liabilities for the quarter that ended in Mar. 2025 was €709.3 Mil.

Tandem Diabetes Care's quarterly Total Liabilities increased from Sep. 2024 (€648.74 Mil) to Dec. 2024 (€672.86 Mil) and increased from Dec. 2024 (€672.86 Mil) to Mar. 2025 (€709.34 Mil).

Tandem Diabetes Care's annual Total Liabilities increased from Dec. 2022 (€578.52 Mil) to Dec. 2023 (€585.99 Mil) and increased from Dec. 2023 (€585.99 Mil) to Dec. 2024 (€672.86 Mil).


Tandem Diabetes Care Total Liabilities Historical Data

The historical data trend for Tandem Diabetes Care's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Total Liabilities Chart

Tandem Diabetes Care Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 287.79 417.74 578.52 585.99 672.86

Tandem Diabetes Care Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 642.14 653.67 648.74 672.86 709.34

Tandem Diabetes Care Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Tandem Diabetes Care's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=235.932+(396.026+30.912
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+9.985+0+0)
=672.9

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=924.113-251.259
=672.9

Tandem Diabetes Care's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=266.562+(399.372+34.284
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+9.119+0+0)
=709.3

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=852.982-143.645
=709.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tandem Diabetes Care Total Liabilities Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Tandem Diabetes Care Business Description

Traded in Other Exchanges
Address
12400 High Bluff Drive, San Diego, CA, USA, 92130
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care Headlines

No Headlines